223 related articles for article (PubMed ID: 29024688)
1. Vitiligo Skin: Exploring the Dermal Compartment.
Kovacs D; Bastonini E; Ottaviani M; Cota C; Migliano E; Dell'Anna ML; Picardo M
J Invest Dermatol; 2018 Feb; 138(2):394-404. PubMed ID: 29024688
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of tenascin-C in vitiligo.
Abdou AG; Maraee AH; Shoeib MA; Elbana R
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
[TBL] [Abstract][Full Text] [Related]
3. Senescence in the lesional fibroblasts of non-segmental vitiligo patients.
Rani S; Bhardwaj S; Srivastava N; Sharma VL; Parsad D; Kumar R
Arch Dermatol Res; 2017 Mar; 309(2):123-132. PubMed ID: 28078437
[TBL] [Abstract][Full Text] [Related]
4. Involvement of non-melanocytic skin cells in vitiligo.
Bastonini E; Bellei B; Filoni A; Kovacs D; Iacovelli P; Picardo M
Exp Dermatol; 2019 Jun; 28(6):667-673. PubMed ID: 30582762
[TBL] [Abstract][Full Text] [Related]
5. Effect of Dickkopf1 on the senescence of melanocytes: in vitro study.
Rani S; Chauhan R; Parsad D; Kumar R
Arch Dermatol Res; 2018 May; 310(4):343-350. PubMed ID: 29442138
[TBL] [Abstract][Full Text] [Related]
6. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of perforin and apoptosis stimulation fragment ligand (FasL)in active vitiligo.
Hassan AS; Kohil MM; Sayed SSE; Mahmoud SB
Arch Dermatol Res; 2021 Aug; 313(6):453-460. PubMed ID: 32785835
[TBL] [Abstract][Full Text] [Related]
8. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
9. Melanocytes are not absent in lesional skin of long duration vitiligo.
Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of neuregulin1 in the lesional skin of vitiligo patients.
Rani S; Kumari U; Bhardwaj S; Parsad D; Sharma VL; Kumar R
Int J Dermatol; 2019 Feb; 58(2):242-249. PubMed ID: 30074619
[TBL] [Abstract][Full Text] [Related]
11. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
12. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.
Lee AY; Kim NH; Choi WI; Youm YH
J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039
[TBL] [Abstract][Full Text] [Related]
13. Vitiligo: a possible model of degenerative diseases.
Bellei B; Pitisci A; Ottaviani M; Ludovici M; Cota C; Luzi F; Dell'Anna ML; Picardo M
PLoS One; 2013; 8(3):e59782. PubMed ID: 23555779
[TBL] [Abstract][Full Text] [Related]
14. In vivo reflectance confocal microscopy imaging of vitiligo, nevus depigmentosus and nevus anemicus.
Lai LG; Xu AE
Skin Res Technol; 2011 Nov; 17(4):404-10. PubMed ID: 21429011
[TBL] [Abstract][Full Text] [Related]
15. Th17 cells and activated dendritic cells are increased in vitiligo lesions.
Wang CQ; Cruz-Inigo AE; Fuentes-Duculan J; Moussai D; Gulati N; Sullivan-Whalen M; Gilleaudeau P; Cohen JA; Krueger JG
PLoS One; 2011 Apr; 6(4):e18907. PubMed ID: 21541348
[TBL] [Abstract][Full Text] [Related]
16. Impact of ultraviolet radiation on dermal and epidermal DNA damage in a human pigmented bilayered skin substitute.
Goyer B; Pereira U; Magne B; Larouche D; Kearns-Turcotte S; Rochette PJ; Martin L; Germain L
J Tissue Eng Regen Med; 2019 Dec; 13(12):2300-2311. PubMed ID: 31502756
[TBL] [Abstract][Full Text] [Related]
17. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
[TBL] [Abstract][Full Text] [Related]
18. Premature cell senescence in human skin: Dual face in chronic acquired pigmentary disorders.
Bellei B; Picardo M
Ageing Res Rev; 2020 Jan; 57():100981. PubMed ID: 31733332
[TBL] [Abstract][Full Text] [Related]
19. Epidermal hydrogen peroxide is not increased in lesional and non-lesional skin of vitiligo.
Zailaie MZ
Arch Dermatol Res; 2017 Jan; 309(1):31-42. PubMed ID: 27783153
[TBL] [Abstract][Full Text] [Related]
20. Glabrous lesional stem cells differentiated into functional melanocytes: new hope for repigmentation.
Kumar R; Parsad D; Rani S; Bhardwaj S; Srivastav N
J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1555-60. PubMed ID: 27538731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
